Advertisement
Screener

Verastem, Inc. (VSTM) Net Income

Verastem, Inc. Net Income

Verastem, Inc. (VSTM) reported Net Income of -$34.67 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2026-08-06

  • Verastem, Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$34.67M.
  • Verastem, Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$36.59M.
  • Verastem, Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$32.92M.
  • Verastem, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$98.52M.
  • Verastem, Inc. net income (loss) attributable to parent for fiscal 2022 was -$73.81M.
  • Verastem, Inc. net income (loss) attributable to parent for fiscal 2021 was -$71.20M.
  • Verastem, Inc. net income (loss) attributable to parent for fiscal 2020 was -$67.73M.
  • Verastem, Inc. net income (loss) attributable to parent for fiscal 2019 was -$149.21M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 5 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 20 monthNet Income (Loss) Attributable to Parent 23 monthNet Income (Loss) Attributable to Parent 26 monthNet Income (Loss) Attributable to Parent 29 monthNet Income (Loss) Attributable to Parent 32 monthNet Income (Loss) Attributable to Parent 35 monthNet Income (Loss) Attributable to Parent 38 monthNet Income (Loss) Attributable to Parent 41 monthNet Income (Loss) Attributable to Parent 44 month
2026-06-30-$34.67M
10-Q · filed 2026-08-06
-$71.26M
10-Q · filed 2026-08-06
-$104.18M
derived: sum of 3 quarters · filed 2026-08-06
-$202.70M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$36.59M
10-Q · filed 2026-08-06
-$69.51M
derived: sum of 2 quarters · filed 2026-08-06
-$168.03M
derived: sum of 3 quarters · filed 2026-08-06
-$193.96M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$32.92M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-09
-$131.43M
derived: sum of 2 quarters · filed 2026-04-09
-$157.37M
derived: sum of 3 quarters · filed 2026-08-06
-$209.47M
DEF 14A · filed 2026-04-09
2025-09-30-$98.52M
10-Q · filed 2025-11-04
-$124.45M
derived: sum of 2 quarters · filed 2026-08-06
-$176.56M
10-Q · filed 2025-11-04
-$241.11M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$25.93M
10-Q · filed 2026-08-06
-$78.04M
10-Q · filed 2026-08-06
-$142.59M
derived: sum of 3 quarters · filed 2026-08-06
-$166.56M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$52.10M
10-Q · filed 2026-08-06
-$116.65M
derived: sum of 2 quarters · filed 2026-08-06
-$140.62M
derived: sum of 3 quarters · filed 2026-08-06
-$148.88M
derived: sum of 4 quarters · filed 2026-08-06
2024-12-31-$64.55M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-09
-$88.52M
derived: sum of 2 quarters · filed 2026-04-09
-$96.77M
derived: sum of 3 quarters · filed 2026-04-09
-$130.64M
DEF 14A · filed 2026-04-09
2024-09-30-$23.97M
10-Q · filed 2025-11-04
-$32.22M
derived: sum of 2 quarters · filed 2025-11-04
-$66.09M
10-Q · filed 2025-11-04
-$93.45M
derived: sum of 4 quarters · filed 2026-04-09
2024-06-30-$8.26M
10-Q · filed 2025-11-04
-$42.12M
10-Q · filed 2025-08-07
-$69.49M
derived: sum of 3 quarters · filed 2026-04-09
-$89.49M
derived: sum of 4 quarters · filed 2026-04-09
2024-03-31-$33.86M
10-Q · filed 2025-11-04
-$61.23M
derived: sum of 2 quarters · filed 2026-04-09
-$81.23M
derived: sum of 3 quarters · filed 2026-04-09
-$105.52M
derived: sum of 4 quarters · filed 2026-04-09
2023-12-31-$27.37M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-09
-$47.37M
derived: sum of 2 quarters · filed 2026-04-09
-$71.65M
derived: sum of 3 quarters · filed 2026-04-09
-$87.37M
DEF 14A · filed 2026-04-09
2023-09-30-$20.00M
10-Q · filed 2024-11-06
-$44.28M
derived: sum of 2 quarters · filed 2024-11-06
-$60.00M
10-Q · filed 2024-11-06
-$76.81M
derived: sum of 4 quarters · filed 2025-03-20
2023-06-30-$24.28M
10-Q · filed 2024-11-06
-$39.99M
10-Q · filed 2024-08-08
-$56.80M
derived: sum of 3 quarters · filed 2025-03-20
-$74.89M
derived: sum of 4 quarters · filed 2025-03-20
2023-03-31-$15.71M
10-Q · filed 2024-11-06
-$32.52M
derived: sum of 2 quarters · filed 2025-03-20
-$50.61M
derived: sum of 3 quarters · filed 2025-03-20
-$72.56M
derived: sum of 4 quarters · filed 2025-03-20
2022-12-31-$16.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
-$34.90M
derived: sum of 2 quarters · filed 2025-03-20
-$56.85M
derived: sum of 3 quarters · filed 2025-03-20
-$73.81M
10-K · filed 2025-03-20
2022-09-30-$18.09M
10-Q · filed 2023-11-08
-$40.04M
derived: sum of 2 quarters · filed 2023-11-08
-$57.00M
10-Q · filed 2023-11-08
-$73.48M
derived: sum of 4 quarters · filed 2024-03-14
2022-06-30-$21.95M
10-Q · filed 2023-11-08
-$38.91M
10-Q · filed 2023-08-08
-$55.40M
derived: sum of 3 quarters · filed 2024-03-14
-$78.18M
derived: sum of 4 quarters · filed 2024-03-14
2022-03-31-$16.96M
10-Q · filed 2023-11-08
-$33.44M
derived: sum of 2 quarters · filed 2024-03-14
-$56.23M
derived: sum of 3 quarters · filed 2024-03-14
-$73.13M
derived: sum of 4 quarters · filed 2024-03-14
2021-12-31-$16.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$39.27M
derived: sum of 2 quarters · filed 2024-03-14
-$56.17M
derived: sum of 3 quarters · filed 2024-03-14
-$71.20M
10-K · filed 2024-03-14
2021-09-30-$22.79M
10-Q · filed 2022-11-03
-$39.69M
derived: sum of 2 quarters · filed 2022-11-03
-$54.72M
10-Q · filed 2022-11-03
-$74.58M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30-$16.90M
10-Q · filed 2022-11-03
-$31.93M
10-Q · filed 2022-08-08
-$51.80M
derived: sum of 3 quarters · filed 2022-11-03
-$38.66M
derived: sum of 4 quarters · filed 2022-11-03
2021-03-31-$15.03M
10-Q · filed 2022-11-03
-$34.90M
derived: sum of 2 quarters · filed 2022-11-03
-$21.76M
derived: sum of 3 quarters · filed 2022-11-03
-$44.77M
derived: sum of 4 quarters · filed 2022-11-03
2020-12-31-$19.86M
10-K · filed 2021-03-18
-$6.73M
derived: sum of 2 quarters · filed 2021-11-04
-$29.74M
derived: sum of 3 quarters · filed 2021-11-04
-$67.73M
10-K · filed 2023-03-14
2020-09-30$13.14M
10-Q · filed 2021-11-04
-$9.87M
derived: sum of 2 quarters · filed 2021-11-04
-$47.86M
10-Q · filed 2021-11-04
-$86.64M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30-$23.01M
10-Q · filed 2021-11-04
-$61.00M
10-Q · filed 2021-08-02
-$99.77M
derived: sum of 3 quarters · filed 2021-11-04
-$129.91M
derived: sum of 4 quarters · filed 2021-11-04
2020-03-31-$37.99M
10-Q · filed 2021-11-04
-$76.76M
derived: sum of 2 quarters · filed 2021-11-04
-$106.90M
derived: sum of 3 quarters · filed 2021-11-04
-$149.10M
derived: sum of 4 quarters · filed 2021-11-04
2019-12-31-$38.77M
10-K · filed 2021-03-18
-$68.91M
derived: sum of 2 quarters · filed 2021-03-18
-$111.11M
derived: sum of 3 quarters · filed 2021-03-18
-$149.21M
10-K · filed 2022-03-28
2019-09-30-$30.14M
10-K · filed 2021-03-18
-$72.33M
derived: sum of 2 quarters · filed 2021-03-18
-$110.44M
10-Q · filed 2020-11-09
-$121.78M
derived: sum of 4 quarters · filed 2021-03-18
2019-06-30-$42.19M
10-K · filed 2021-03-18
-$80.30M
10-Q · filed 2020-08-10
-$91.64M
derived: sum of 3 quarters · filed 2021-03-18
-$113.31M
derived: sum of 4 quarters · filed 2021-03-18
2019-03-31-$38.10M
10-K · filed 2021-03-18
-$49.45M
derived: sum of 2 quarters · filed 2021-03-18
-$71.12M
derived: sum of 3 quarters · filed 2021-03-18
-$89.49M
derived: sum of 4 quarters · filed 2021-03-18
2018-12-31-$11.35M
10-K · filed 2020-03-11
-$33.02M
derived: sum of 2 quarters · filed 2020-03-11
-$51.38M
derived: sum of 3 quarters · filed 2020-03-11
-$72.43M
10-K · filed 2021-03-18
2018-09-30-$21.67M
10-K · filed 2020-03-11
-$40.03M
derived: sum of 2 quarters · filed 2020-03-11
-$61.09M
10-Q · filed 2019-10-30
-$79.32M
derived: sum of 4 quarters · filed 2020-03-11
2018-06-30-$18.37M
10-K · filed 2020-03-11
-$39.42M
10-Q · filed 2019-08-01
-$57.65M
derived: sum of 3 quarters · filed 2020-03-11
-$80.78M
derived: sum of 4 quarters · filed 2020-03-11
2018-03-31-$21.05M
10-K · filed 2020-03-11
-$39.28M
derived: sum of 2 quarters · filed 2020-03-11
-$62.41M
derived: sum of 3 quarters · filed 2020-03-11
-$75.85M
derived: sum of 4 quarters · filed 2020-03-11
2017-12-31-$18.23M
10-K · filed 2019-03-12
-$41.36M
derived: sum of 2 quarters · filed 2019-03-12
-$54.80M
derived: sum of 3 quarters · filed 2019-03-12
-$67.80M
10-K · filed 2020-03-11
2017-09-30-$23.13M
10-K · filed 2019-03-12
-$36.56M
derived: sum of 2 quarters · filed 2019-03-12
-$49.57M
10-Q · filed 2018-11-07
-$61.22M
derived: sum of 4 quarters · filed 2019-03-12
2017-06-30-$13.44M
10-K · filed 2019-03-12
-$26.44M
10-Q · filed 2018-08-08
-$38.10M
derived: sum of 3 quarters · filed 2019-03-12
-$46.02M
derived: sum of 4 quarters · filed 2019-03-12
2017-03-31-$13.01M
10-K · filed 2019-03-12
-$24.66M
derived: sum of 2 quarters · filed 2019-03-12
-$32.58M
derived: sum of 3 quarters · filed 2019-03-12
-$41.15M
derived: sum of 4 quarters · filed 2019-03-12
2016-12-31-$11.65M
10-K · filed 2018-03-13
-$19.58M
derived: sum of 2 quarters · filed 2018-03-13
-$28.15M
derived: sum of 3 quarters · filed 2018-03-13
-$36.44M
10-K · filed 2019-03-12
2016-09-30-$7.92M
10-K · filed 2018-03-13
-$16.49M
derived: sum of 2 quarters · filed 2018-03-13
-$24.79M
10-Q · filed 2017-11-07
-$36.65M
derived: sum of 4 quarters · filed 2018-03-13
2016-06-30-$8.57M
10-K · filed 2018-03-13
-$16.86M
10-Q · filed 2017-08-08
-$28.73M
derived: sum of 3 quarters · filed 2018-03-13
-$44.17M
derived: sum of 4 quarters · filed 2018-03-13
2016-03-31-$8.29M
10-K · filed 2018-03-13
-$20.16M
derived: sum of 2 quarters · filed 2018-03-13
-$35.60M
derived: sum of 3 quarters · filed 2018-03-13
-$50.98M
derived: sum of 4 quarters · filed 2018-03-13
2015-12-31-$11.86M
10-K · filed 2016-03-03
-$27.31M
derived: sum of 2 quarters · filed 2016-11-07
-$42.69M
derived: sum of 3 quarters · filed 2016-11-07
-$57.87M
10-K · filed 2018-03-13
2015-09-30-$15.45M
10-Q · filed 2016-11-07
-$30.82M
derived: sum of 2 quarters · filed 2016-11-07
-$46.00M
10-Q · filed 2016-11-07
-$59.95M
derived: sum of 4 quarters · filed 2016-11-07
2015-06-30-$15.38M
10-Q · filed 2016-08-08
-$30.56M
10-Q · filed 2016-08-08
-$44.51M
derived: sum of 3 quarters · filed 2016-08-08
-$57.84M
derived: sum of 4 quarters · filed 2016-08-08
2015-03-31-$15.18M
10-Q · filed 2016-05-09
-$29.13M
derived: sum of 2 quarters · filed 2016-05-09
-$42.46M
derived: sum of 3 quarters · filed 2016-05-09
-$55.48M
derived: sum of 4 quarters · filed 2016-05-09
2014-12-31-$13.95M
10-K · filed 2016-03-03
-$27.28M
derived: sum of 2 quarters · filed 2016-03-03
-$40.30M
derived: sum of 3 quarters · filed 2016-03-03
-$53.37M
10-K · filed 2016-03-03
2014-09-30-$13.33M
10-K · filed 2016-03-03
-$26.35M
derived: sum of 2 quarters · filed 2016-03-03
-$39.42M
10-Q · filed 2015-11-09
-$50.74M
derived: sum of 4 quarters · filed 2016-03-03
2014-06-30-$13.02M
10-K · filed 2016-03-03
-$26.08M
10-Q · filed 2015-08-10
-$37.41M
derived: sum of 3 quarters · filed 2016-03-03
-$48.00M
derived: sum of 4 quarters · filed 2016-03-03
2014-03-31-$13.06M
10-K · filed 2016-03-03
-$24.39M
derived: sum of 2 quarters · filed 2016-03-03
-$34.98M
derived: sum of 3 quarters · filed 2016-03-03
-$45.23M
derived: sum of 4 quarters · filed 2016-03-03
-$100.72M
10-Q · filed 2014-05-08
2013-12-31-$11.32M
10-K · filed 2015-03-10
-$21.91M
derived: sum of 2 quarters · filed 2015-03-10
-$32.16M
derived: sum of 3 quarters · filed 2015-03-10
-$41.20M
10-K · filed 2016-03-03
-$87.65M
10-K · filed 2014-03-06
2013-09-30-$10.59M
10-K · filed 2015-03-10
-$20.84M
derived: sum of 2 quarters · filed 2015-03-10
-$29.88M
10-Q · filed 2014-10-30
-$37.80M
derived: sum of 4 quarters · filed 2015-03-10
-$76.33M
10-Q · filed 2013-11-12
2013-06-30-$10.25M
10-K · filed 2015-03-10
-$19.29M
10-Q · filed 2014-08-07
-$27.21M
derived: sum of 3 quarters · filed 2015-03-10
-$37.58M
derived: sum of 4 quarters · filed 2015-03-10
-$65.74M
10-Q · filed 2013-08-13
2013-03-31-$9.04M
10-K · filed 2015-03-10
-$16.96M
derived: sum of 2 quarters · filed 2015-03-10
-$27.32M
derived: sum of 3 quarters · filed 2015-03-10
-$34.15M
derived: sum of 4 quarters · filed 2015-03-10
-$55.49M
10-Q · filed 2013-05-09
2012-12-31-$7.92M
10-K · filed 2014-03-06
-$18.29M
derived: sum of 2 quarters · filed 2014-03-06
-$25.11M
derived: sum of 3 quarters · filed 2014-03-06
-$31.98M
10-K · filed 2015-03-10
-$46.45M
10-K · filed 2013-03-26
2012-09-30-$10.37M
10-K · filed 2014-03-06
-$17.19M
derived: sum of 2 quarters · filed 2014-03-06
-$24.06M
10-Q · filed 2013-11-12
-$30.07M
derived: sum of 4 quarters · filed 2014-03-06
-$38.53M
10-Q · filed 2012-11-13
2012-06-30-$6.83M
10-K · filed 2014-03-06
-$13.70M
10-Q · filed 2013-08-13
-$19.70M
derived: sum of 3 quarters · filed 2014-03-06
-$23.75M
derived: sum of 4 quarters · filed 2014-03-06
-$28.16M
10-Q · filed 2012-08-13
2012-03-31-$6.87M
10-K · filed 2014-03-06
-$12.88M
derived: sum of 2 quarters · filed 2014-03-06
-$16.92M
derived: sum of 3 quarters · filed 2014-03-06
-$19.41M
derived: sum of 4 quarters · filed 2014-03-06
-$21.34M
10-Q · filed 2012-05-14
2011-12-31-$6.00M
10-K · filed 2013-03-26
-$10.05M
derived: sum of 2 quarters · filed 2013-03-26
-$12.54M
derived: sum of 3 quarters · filed 2013-03-26
-$13.68M
10-K · filed 2014-03-06
2011-09-30-$4.05M
10-K · filed 2013-03-26
-$6.53M
derived: sum of 2 quarters · filed 2013-03-26
-$7.68M
10-Q · filed 2012-11-13
2011-06-30-$2.48M
10-K · filed 2013-03-26
-$3.63M
10-Q · filed 2012-08-13
2011-03-31-$1.15M
10-K · filed 2013-03-26
2010-12-31-$784.00K
10-K · filed 2014-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Faeth Therapeutics, Inc. (FTH)United States$0.750B
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Wave Life Sciences, Inc. (WVE)$0.780B-5.56